ChemicalBook > CAS DataBase List > Fmoc-Lys(Pal-Glu-OtBu)-OH

Fmoc-Lys(Pal-Glu-OtBu)-OH

Product Name
Fmoc-Lys(Pal-Glu-OtBu)-OH
CAS No.
1491158-62-3
Chemical Name
Fmoc-Lys(Pal-Glu-OtBu)-OH
Synonyms
Liraglutide Lys;Fmoc-Lys(Pal-Glu-OtBu);Fmoc-Lys(Pal-Glu-OtBu)-OH;Palm-Glu(Ot-Bu)-Fmoc-Lys-OH;Fmoc-L-Lys(Palm-L-Glu-OtBu)-OH;PLU-3(Fmoc-L-Lys(Palm-L-Glu-Otbu)-OH);Fmoc-L-Lys(Palm-L-Glu-OtBu)-OH main building block;(9H-Fluoren-9-yl)MethOxy]Carbonyl Lys(Pal-Glu-OtBu)-OH;N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-((S)-5-(tert-butoxy)-5-oxo-4-palmitamidopentanoyl)-L-lysine;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-(N-alpha'-palmitoyl-L-glutamic-acid alpha'-t-butyl ester)-L-lysine
CBNumber
CB13054762
Molecular Formula
C46H69N3O8
Formula Weight
792.06
MOL File
1491158-62-3.mol
More
Less

Fmoc-Lys(Pal-Glu-OtBu)-OH Property

Boiling point:
944.2±65.0 °C(Predicted)
Density 
1.099±0.06 g/cm3(Predicted)
pka
3.88±0.21(Predicted)
form 
Solid
color 
White to off-white
InChIKey
SUFBOZUGILQOQW-FMQAFZDONA-N
SMILES
C(O)(=O)[C@@H](N(C1C2=C(C=CC=C2)C2=C1C=CC=C2)C(OC)=O)CCCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(OC(C)(C)C)=O |&1:3,31,r|
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TRC
Product number
H950213
Product name
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4S)-4-(hexadecanoylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]amino]hexanoicacid
Packaging
50mg
Price
$155
Updated
2021/12/16
ChemScene
Product number
CS-0038825
Product name
Fmoc-Lys(Pal-Glu-OtBu)-OH
Packaging
1g
Price
$230
Updated
2021/12/16
ChemPep
Product number
181247
Product name
Fmoc-Lys(Pal-Glu-OtBu)-OH
Packaging
1g
Price
$250
Updated
2021/12/16
ChemScene
Product number
CS-0038825
Product name
Fmoc-Lys(Pal-Glu-OtBu)-OH
Packaging
100mg
Price
$60
Updated
2021/12/16
ChemScene
Product number
CS-0038825
Product name
Fmoc-Lys(Pal-Glu-OtBu)-OH
Packaging
250mg
Price
$115
Updated
2021/12/16
More
Less

Fmoc-Lys(Pal-Glu-OtBu)-OH Chemical Properties,Usage,Production

Uses

Fmoc-Lys(Pal-Glu-OtBu)-OH can be used as organic synthesis intermediate and pharmaceutical intermediate, mainly used in laboratory research and development process and chemical production process.

Uses

Fmoc-Lys (Pal-Glu-OtBu)-OH is a non-cleavable antibody-drug conjugates linker capable of synthesizing antibody-drug conjugates. It can also be used as an alkyl chain-based PROTAC linker for the synthesis of PROTACs.

Application

Fmoc-Lys(Pal-Glu-OtBu)-OH is a racemic, solid-phase, industrial building block for the synthesis of peptides and polypeptides. This product is used in the synthesis of liraglutide (a peptide), which is used to treat type 2 diabetes mellitus. It is synthesized by a solid phase process using coupling reactions with an acid labile linker. This product has been shown to be an efficient building block for the synthesis of peptides and polypeptides that have a sequence that can be varied by changing the protecting group on the amino acid.

Biological Activity

ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2].

Synthesis


In a flask aqueous sodium carbonate (1.8 g) was prepared followed by addition of THF (800 mL) and then this mixture was cooled to 0-10 0C. To this mixture, (S)-2-((((9Hfluoren-9-yl)methoxy)carbonyl)amino)-6-aminohexanoic acid (4.59 g) was added. Then, a solution of 1 -(tert-butyl) 5-(2,5-dioxopyrrolidin-1-yl) palmitoyl-L-glutamate (corresponding to 5 g of 5-(tert-butoxy)-5-oxo-4-palmitamidopentanoic acid) prepared according to example 2, was slowly added to above mixture at about 5 0C. The reaction mixture was stirred for about 2 hours at 25 0C followed by addition of water (600 mL). The solvents were subjected to distillation and then the pH of the obtained compound is adjusted to 3.0 using 5N hydrochloric acid. The mixture was stirred for 1-2 hours and resulting solid was isolated filtration, washing with water (30 mL). The obtained solid was dried under vacuum for 8 hours at about 45°C to afford title compound in -85% yield.

References

[1] Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337.    
[2] Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985.

Fmoc-Lys(Pal-Glu-OtBu)-OH Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Fmoc-Lys(Pal-Glu-OtBu)-OH Suppliers

More
Less

View Lastest Price from Fmoc-Lys(Pal-Glu-OtBu)-OH manufacturers

Sichuan HongRi Pharma-Tech Co.,Ltd
Product
Fmoc-Lys(Pal-Glu-OtBu)-OH 1491158-62-3
Price
US $0.00-0.00/kg
Min. Order
1kg
Purity
98%
Supply Ability
1T+
Release date
2024-02-28
XIAMEN SINOPEG BIOTECH CO., LTD.
Product
Fmoc-Lys-(Pal-Glu-OtBu)-OH 1491158-62-3
Price
US $0.00-0.00/g
Min. Order
1g
Purity
98%
Supply Ability
1g/bottle, 10g/bottle, 100g/bottle
Release date
2024-07-26
Hebei Mingeng Biotechnology Co., Ltd
Product
Fmoc-Lys(Pal-Glu-Otbu)-OH 1491158-62-3
Price
US $150.00/ASSAYS
Min. Order
10g
Purity
more than 99.6%
Supply Ability
500kg/month
Release date
2021-11-24

1491158-62-3, Fmoc-Lys(Pal-Glu-OtBu)-OHRelated Search:


  • Fmoc-Lys(Pal-Glu-OtBu)-OH
  • N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N6-[N-(1-oxohexadecyl)-L-gamma-glutamyl]-L-lysine 1'-(1,1-dimethylethyl) ester
  • (S)-2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-6-((S)-5-(Tert-Butoxy)-5-Oxo-4-Palmitamidopentanamido)Hexanoic Acid
  • (9H-Fluoren-9-yl)MethOxy]Carbonyl Lys(Pal-Glu-OtBu)-OH
  • N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-(N-alpha'-palmitoyl-L-glutamic-acid alpha'-t-butyl ester)-L-lysine
  • Fmoc-L-Lys(Palm-L-Glu-OtBu)-OH
  • (2S)-6-[(4S)-5-(tert-butoxy)-4-hexadecanamido-5-oxopentanamido]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid
  • L-Lysine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N6-[N-(1-oxohexadecyl)-L-γ-glutamyl]-, 1'-(1,1-dimethylethyl) ester
  • (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4S)-4-(hexadecanoylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]amino]hexanoic acid
  • Liraglutide Lys
  • PLU-3(Fmoc-L-Lys(Palm-L-Glu-Otbu)-OH)
  • Fmoc-Lys(Pal-Glu-OtBu)
  • N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-((S)-5-(tert-butoxy)-5-oxo-4-palmitamidopentanoyl)-L-lysine
  • Fmoc-L-Lys(Palm-L-Glu-OtBu)-OH main building block
  • Palm-Glu(Ot-Bu)-Fmoc-Lys-OH
  • (2S)-6-{[(4S)-5-tert-butoxy-4-(hexadecanoylamino)-5-oxopentanoyl]amino}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid
  • 1491158-62-3
  • C46H69N3O8